Market revenue in 2022 | USD 1,483.9 million |
Market revenue in 2030 | USD 9,288.3 million |
Growth rate | 25.8% (CAGR from 2022 to 2030) |
Largest segment | Car t cell therapy |
Fastest growing segment | CAR T Cell Therapy |
Historical data covered | 2018 - 2021 |
Base year for estimation | 2022 |
Forecast period covered | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | CAR T Cell Therapy, Dendritic Cell Therapy, NK Cell Therapy, TIL Therapy |
Key market players worldwide | BioTelemetry, Biotricity Inc, Welch Allyn, Boston Scientific Corp, ZOLL Medical Corporation, IRhythm Technologies Inc, ACS Diagnostics, Medicomp, Telerhythmics |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to cellular immunotherapy market will help companies and investors design strategic landscapes.
Car t cell therapy was the largest segment with a revenue share of 72.4% in 2022. Horizon Databook has segmented the Asia Pacific cellular immunotherapy market based on car t cell therapy, dendritic cell therapy, nk cell therapy, til therapy covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific cellular immunotherapy market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific cellular immunotherapy market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account